Login / Signup

Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: a 24-week double-blind prospective randomized controlled trial.

Clémence BertoldEric FontasTanya SinghNadia GastautSandra RuitortSylvia Wehrlen PuglieseThierry Passeron
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
The NT combination appears to be an effective treatment option for treating melasma and could be considered as a well-tolerated alternative to KT.
Keyphrases
  • randomized controlled trial
  • study protocol
  • placebo controlled
  • double blind
  • clinical trial
  • systematic review
  • phase iii